Martine A Rothblatt sold $1.1M of UTHR
Chairperson & CEO at UNITED THERAPEUTICS Corp. 1,920 shares at an average of $550.22, traded Sep 30, 2026, filed Oct 1, 2026.
Score components
- +25RoleCEO
- +25Trade size$1.1M at market
- 0Share of holdings soldSold 0.6% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001106578-26-000154, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -400 | $547.29 | $219k | 325,963 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -280 | $548.25 | $154k | 325,683 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -240 | $549.40 | $132k | 325,443 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -400 | $550.47 | $220k | 325,043 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -160 | $551.50 | $88k | 324,883 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -120 | $552.63 | $66k | 324,763 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -113 | $553.78 | $63k | 324,650 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -207 | $554.70 | $115k | 324,443 | 10 d ago |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.5M 9,500 shares | -3% | |
| 18Weak | UNITED THERAPEUTICS Corp | Paul A Mahon EVP & GENERAL COUNSEL | $4.7M 8,300 shares | -16% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $3.9M 7,580 shares | -2% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.5M 9,500 shares | -3% | |
| 30Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.6M 9,500 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.